| 2021 | | Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer | 강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁 |
| 2024 | | Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment | 안미선, 윤준기 |
| 2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
| 2016 | | Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients | 박준성, 이위교, 임영애, 정성현, 조성란 |
| 1996 | | Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. | 김진홍, 김효철, 이광재, 조성원, 함기백 |
| 2023 | | Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation | 정성현, 최윤석 |
| 2013 | | Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer. | 강두경, 강석윤, 김구상, 김지영, 김태희, 박래웅, 안미선, 안영실, 임현이, 전자영, 정용식 |
| 2022 | | Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations | 안미선 |
| 2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments | 강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환 |
| 2023 | | Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) | 최진혁 |
| 2023 | | Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response | 권민석 |
| 2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
| 2009 | | Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer | 강석윤, 박광주, 신승수, 안미선, 오영택, 이현우, 정성현, 최진혁 |
| 1996 | | Concurrent presentation of erythrocytic and megakaryocytic aplasia. | 김효철 |
| 2018 | | Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment | 이현우 |
| 2021 | | Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488] | 강석윤 |
| 2021 | | Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux | 김철호, 박준성, 정성현, 최용원 |
| 2013 | | Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea | 박준성, 박준은, 이현우, 정성현, 조성란 |
| 2023 | | Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404) | 정성현 |
| 2020 | | DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network | 이현우 |
| 2020 | | DeepBTS: Prediction of recurrence-free survival of non-small cell lung cancer using time-binned deep neural network | 이현우 |
| 2004 | | Delivery in a Patient with Paroxysmal Nocturnal Hemoglobinuria Successfully Managed with Low Molecular Weight Heparin Therapy | 김행수, 김효철, 양정인, 유희석, 장혜진 |
| 2009 | | Dermatomyositis with Diffuse Large B Cell Lymphoma | 김현아, 김효철, 서창희, 한재호 |
| 1997 | | Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. | 최진혁 |
| 2021 | | Development of population-based cancer indicators and a measurement of cancer care continuum using a modified delphi method | 박진희, 안미선, 전미선, 정승연, 조오연 |
| 2017 | | Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma | 김보현, 김재근, 김지훈, 노오규, 오영택, 이제희, 이현우, 전미선, 조오연, 허재성 |
| 2000 | | Dichotomy between Tc-99m MDP bone scan and fluorine-18 fluorodeoxyglucose coincidence detection positron emission tomography in patients with non-Hodgkin's lymphoma. | 김현수, 김효철, 박찬희 |
| 2009 | | Difference in Viability of CD34+ Cells in Cryopreserved Cord Blood According to Evaluation Methods | 강석윤, 김효철, 박준성, 이현우, 정성현, 최진혁 |
| 2012 | | Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis | 강두경, 강석윤, 김구상, 김태희, 박래웅, 안영실, 오기근, 임현이, 전미선, 정용식 |
| 2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
| 2019 | | Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy? | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
| 2013 | | Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis. | 남동호, 박준성 |
| 2022 | | Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study | 박준성 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 1997 | | Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. | 김효철 |
| 2018 | | Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy | 강석윤 |
| 2016 | | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study | 박준성, 정성현 |
| 2014 | | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. | 박준성, 정성현 |
| 2018 | | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | 이현우 |
| 2021 | | Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | 이현우 |
| 2020 | | Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial | 강석윤 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2019 | | EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment | 강석윤 |
| 2007 | | Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. | 강석윤, 김효철, 박준성, 이현우, 최진혁 |
| 2022 | | Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2020 | | Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931) | 안미선 |
